✦ LIBER ✦

Cardiovascular Risk Factors and Estimated Risk for CAD in a Randomized Trial Comparing Calcineurin Inhibitors in Renal Transplantation

✍ Scribed by Bernhard K. Krämer; Carl Zülke; Martin C. Kammerl; Christian Schmidt; Christian Hengstenberg; Michael Fischereder; Jörg Marienhagen; European Tacrolimus vs. Cyclosporine Microemulsion Renal Transplantation Study Group

Book ID: 114423627
Publisher: John Wiley and Sons
Year: 2003
Tongue: English
Weight: 77 KB
Volume: 3
Category: Article
ISSN: 1600-6135
DOI: 10.1034/j.1600-6143.2003.00156.x

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Cardiovascular Risk Estimates and Risk F

Cardiovascular Risk Estimates and Risk Factors in Renal Transplant Recipients

✍ B.K. Krämer; C. Böger; B. Krüger; J. Marienhagen; M. Pietrzyk; A. Obed; L. Pacze 📂 Article 📅 2005 🏛 Elsevier Science 🌐 English ⚖ 59 KB

Complete Avoidance of Calcineurin Inhibi

Complete Avoidance of Calcineurin Inhibitors in Renal Transplantation: A Randomized Trial Comparing Sirolimus and Tacrolimus

✍ T. S. Larson; P. G. Dean; M. D. Stegall; M. D. Griffin; S. C. Textor; T. R. Schw 📂 Article 📅 2006 🏛 John Wiley and Sons 🌐 English ⚖ 282 KB

Cardiovascular risk factors of sirolimus

Cardiovascular risk factors of sirolimus compared with cyclosporine: early experience from two randomized trials in renal transplantation

✍ C Legendre; J.M Campistol; J.-P Squifflet; J.T Burke 📂 Article 📅 2003 🏛 Elsevier Science 🌐 English ⚖ 83 KB

Risk factors for cardiovascular disease

Risk factors for cardiovascular disease in renal transplant recipients and strategies to minimize risk

✍ Lutz Liefeldt; Klemens Budde 📂 Article 📅 2010 🏛 Springer 🌐 English ⚖ 257 KB

Renal Dysfunction Is a Strong and Indepe

Renal Dysfunction Is a Strong and Independent Risk Factor for Mortality and Cardiovascular Complications in Renal Transplantation

✍ B. Fellström; A. G. Jardine; I. Soveri; E. Cole; H.-H. Neumayer; B. Maes; C. Gim 📂 Article 📅 2005 🏛 John Wiley and Sons 🌐 English ⚖ 94 KB

Effects of cerivastatin in dyslipemia an

Effects of cerivastatin in dyslipemia and other cardiovascular risk factors after renal transplantation

✍ I Garcia; P Errasti; F.J Lavilla; B Ballester; J Manrique; E Rossich; A Purroy 📂 Article 📅 2002 🏛 Elsevier Science 🌐 English ⚖ 45 KB